NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 195 filers reported holding NEKTAR THERAPEUTICS in Q3 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $5,535,000 | -48.7% | 239,000 | -52.2% | 0.16% | -62.8% |
Q4 2019 | $10,793,000 | -46.1% | 500,000 | -54.5% | 0.42% | -48.1% |
Q3 2019 | $20,037,000 | -29.6% | 1,100,000 | +37.5% | 0.80% | -30.2% |
Q2 2019 | $28,464,000 | -15.3% | 800,000 | -20.0% | 1.15% | -16.1% |
Q1 2019 | $33,600,000 | +2.2% | 1,000,000 | 0.0% | 1.37% | +12.7% |
Q4 2018 | $32,870,000 | -46.1% | 1,000,000 | 0.0% | 1.22% | -23.3% |
Q3 2018 | $60,960,000 | +4.0% | 1,000,000 | -16.7% | 1.59% | +27.4% |
Q2 2018 | $58,596,000 | -38.7% | 1,200,000 | +33.3% | 1.24% | +4.0% |
Q1 2018 | $95,634,000 | +6.8% | 900,000 | -40.0% | 1.20% | -11.4% |
Q4 2017 | $89,580,000 | +101.8% | 1,500,000 | -18.9% | 1.35% | +76.6% |
Q3 2017 | $44,400,000 | -5.4% | 1,850,000 | -22.9% | 0.76% | -6.7% |
Q2 2017 | $46,920,000 | +33.3% | 2,400,000 | +60.0% | 0.82% | +5.0% |
Q1 2017 | $35,205,000 | +91.3% | 1,500,000 | 0.0% | 0.78% | +91.4% |
Q4 2016 | $18,405,000 | +7.1% | 1,500,000 | +50.0% | 0.41% | +20.0% |
Q3 2016 | $17,180,000 | -13.8% | 1,000,000 | -28.6% | 0.34% | -17.3% |
Q2 2016 | $19,922,000 | -27.6% | 1,400,000 | -30.0% | 0.41% | -23.3% |
Q1 2016 | $27,500,000 | +2.0% | 2,000,000 | +25.0% | 0.54% | +5.9% |
Q4 2015 | $26,960,000 | +36.7% | 1,600,000 | -11.1% | 0.51% | +14.7% |
Q3 2015 | $19,728,000 | -7.2% | 1,800,000 | +5.9% | 0.44% | -51.8% |
Q2 2015 | $21,267,000 | -3.3% | 1,700,000 | -15.0% | 0.92% | -10.1% |
Q1 2015 | $22,000,000 | -14.0% | 2,000,000 | +21.2% | 1.02% | +13.4% |
Q4 2014 | $25,575,000 | +28.4% | 1,650,000 | 0.0% | 0.90% | +22.5% |
Q3 2014 | $19,916,000 | -27.7% | 1,650,000 | -23.3% | 0.73% | -34.3% |
Q2 2014 | $27,563,000 | +42.1% | 2,150,000 | +34.4% | 1.12% | +58.8% |
Q1 2014 | $19,392,000 | +6.8% | 1,600,000 | 0.0% | 0.70% | +7.8% |
Q4 2013 | $18,160,000 | -24.4% | 1,600,000 | -30.4% | 0.65% | -16.8% |
Q3 2013 | $24,024,000 | -16.8% | 2,300,000 | -8.0% | 0.78% | -13.9% |
Q2 2013 | $28,875,000 | – | 2,500,000 | – | 0.91% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |